As Administration Releases a Wave of Regulations, are Storms Ahead?


A wave of recent press releases and Federal Register notices finalized several outstanding policy goals for President Trump and HHS. Given the late hour, one might ask: will these regulations stand, or will they change once the administration changes in January?


Bickering in the Back Seat: The Case for All Payer Pricing


In his latest essay entitled “Bickering in the Back Seat: The Case for All Payer Pricing”, Vizient Research Institute executive director Tom Robertson reminisces about a common childhood memory while contemplating the future direction of health care finance. 


What to Consider When Purchasing Mammography Equipment for Your Facility


When digital breast tomosynthesis was approved for mammography by the Food and Drug Administration in 2011, the 3-dimensional technology brought increased insight into women’s health care, but it did not replace 2D imaging. Instead the two systems complemented each other. Today, however, new technology is poised to change that.


A Tale of Two Pandemics


The COVID-19 pandemic, rampant since March, has interrupted life in ways not seen in our country in over a century. With vaccines in development, we just may have a light at the end of the tunnel. The spread of misinformation, the other pandemic, has serious implications for healthcare and no cure in sight. 


It’s Time to Re-evaluate Insurance Coverage for Events With a Deadly Weapon


In settings where employees are entirely focused on providing care, ensuring that patients, visitors and employees alike are safe is of paramount importance. Unfortunately, incidents of violence can occur, and health care providers need to consider how to mitigate and manage these risks.


Health Care Disruption and the Dog that Didn’t Bark


In the year before the global pandemic, Vizient research was calling attention to the vulnerability of the traditional health system business model, highly dependent on enormous profitability on a very small subset of patients to offset unfavorable economics on the bulk of provider volume.



Emergency Medicine Now and in the Future


Have you ever wondered how hospital emergency departments (EDs) got their name when a large majority of the people who visit them are not experiencing an emergency? Should they be called something else, or should they finally serve only those patients with emergencies? These are interesting thoughts and questions; the answers are not easily surmised.


The Perils of a Fire Sale in the Wake of the Pandemic


In his latest blog post, Vizient Research Institute executive director Tom Robertson urges caution when contemplating the merits of additional provider consolidation stemming from the economic impacts of the global crisis. The mere prospect of all payer rate regulation somewhere down the road — hardly a certainty but extraordinarily disruptive were it to occur — makes applying traditional revenue and pricing assumptions to a new normal future increasingly tenuous.


When Perception and Reality Are at Odds: 5 Ways to Get Clinician Buy-in for New Products


From cost-saving initiatives and quality enhancements to the introduction of new technology that will drive procedural efficiencies, there are many reasons for supply chain leaders to introduce new products to clinicians. But how new products are presented can make or break clinician acceptance.


Refocusing on Accreditation Compliance After the Pandemic


Here are five key strategies to help refocus your team during this pandemic and resume proactive, continuous accreditation compliance to help ensure your organization is always “survey ready.”